Deutsche Bank Ag\ Sc Pharmaceuticals Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 31,603 shares of SCPH stock, worth $123,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,603

Previous 82,488 61.69%

Holding current value

$123,883

Previous $292,000 71.58%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$2.63 - $3.68 $133,827 - $187,256	-50,885 Reduced 61.69%	31,603 $83,000
Q4 2024 Feb 14, 2025	BUY	$3.14 - $4.53 $216,860 - $312,859	69,064 Added 514.48%	82,488 $292,000
Q3 2024 Jun 26, 2025	SELL	$4.12 - $5.51 $74,897 - $100,166	-18,179 Reduced 57.52%	13,424 $61,000
Q2 2024 Jun 12, 2025	SELL	$3.51 - $5.21 $63,808 - $94,712	-18,179 Reduced 57.52%	13,424 $58,000
Q2 2024 Aug 14, 2024	SELL	$3.51 - $5.21 $3,187 - $4,730	-908 Reduced 6.34%	13,424 $58,000
Q1 2024 Jun 02, 2025	SELL	$4.86 - $6.39 $83,937 - $110,361	-17,271 Reduced 54.65%	14,332 $71,000
Q1 2024 May 15, 2024	BUY	$4.86 - $6.39 $61,969 - $81,478	12,751 Added 806.51%	14,332 $71,000
Q4 2023 Feb 14, 2024	SELL	$4.7 - $6.63 $70,561 - $99,536	-15,013 Reduced 90.47%	1,581 $9,000
Q3 2023 Nov 09, 2023	BUY	$7.0 - $9.82 $17,955 - $25,188	2,565 Added 18.28%	16,594 $118,000
Q2 2023 Aug 14, 2023	BUY	$8.94 - $11.74 $125,419 - $164,700	14,029 New	14,029 $142,000
Q2 2021 Aug 11, 2021	SELL	$5.19 - $7.38 $23,329 - $33,173	-4,495 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$5.65 - $7.66 $2,423 - $3,286	-429 Reduced 8.71%	4,495 $29,000
Q4 2020 Feb 16, 2021	BUY	$5.17 - $9.41 $7,320 - $13,324	1,416 Added 40.36%	4,924 $26,000
Q3 2020 Nov 12, 2020	BUY	$7.12 - $8.86 $7,362 - $9,161	1,034 Added 41.79%	3,508 $26,000
Q2 2020 Aug 13, 2020	BUY	$7.01 - $10.96 $17,342 - $27,115	2,474 New	2,474 $18,000
Q1 2020 May 14, 2020	SELL	$5.4 - $10.45 $17,371 - $33,617	-3,217 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.1 - $6.21 $13,189 - $19,977	3,217 New	3,217 $18,000
Q3 2019 Nov 14, 2019	SELL	$3.24 - $7.35 $5,929 - $13,450	-1,830 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.48 - $3.76 $16,551 - $25,094	-6,674 Reduced 78.48%	1,830 $5,000
Q1 2019 May 15, 2019	SELL	$2.84 - $4.18 $1,388 - $2,044	-489 Reduced 5.44%	8,504 $25,000
Q4 2018 Feb 14, 2019	SELL	$3.76 - $5.61 $25,154 - $37,530	-6,690 Reduced 42.66%	8,993 $33,000
Q3 2018 Dec 21, 2021	BUY	$4.22 - $6.03 $7,587 - $10,841	1,798 Added 12.95%	15,683 $92,000
Q3 2018 Nov 14, 2018	BUY	$4.22 - $6.03 $346 - $494	82 Added 0.59%	13,885 $80,000
Q2 2018 Apr 21, 2020	BUY	$5.53 - $15.4 $11,369 - $31,662	2,056 Added 17.5%	13,803 $78,000
Q2 2018 Aug 14, 2018	BUY	$5.53 - $15.4 $12,647 - $35,219	2,287 Added 24.18%	11,747 $65,000
Q1 2018 Oct 18, 2019	BUY	$11.62 - $17.32 $19,626 - $29,253	1,689 Added 21.73%	9,460 $117,000
Q1 2018 May 15, 2018	BUY	$11.62 - $17.32 $90,299 - $134,593	7,771 New	7,771 $96,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

36.3M

Call Options Held

121K

Put Options Held

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $107M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account